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Abstract

Gene silencing is a mechanism for eliminating or reducing the gene activity. Gene silencing was first discovered in Petunia accidentally by Napoli et al in 1990 while they were introducing anthocyanin pigment genes for brighter coloured flowers. But to their surprise instead of dose dependent colour elevation in the transgenic plant, colorless flowers and flowers with variegated colours were produced. From the initial few observations and reports it was inferred that the introduction of transgenes or aberrant double-stranded RNA (dsRNA) into the cell, can trigger post-transcriptional silencing of all homologous host genes and/or transgenes. (Napoli et al, 1990) Transgene induced post-transcriptional gene silencing was first detected in plants (van der Krol et al., 1990) and in Drosophila (Pal-Bhadra et al., 1997) where it was called co-suppression. Subsequently the finding emerged in fungi and was called quelling. (Cogoni and Macino, 2000) In animals, PTGS can be induced by dsRNA in a process called RNA interference – RNAi. (Fire et al., 1999) It was found that PTGS can also be induced by viruses expressing host genes in a process called virus-induced gene silencing (VIGS) in plants. Alternatively, the viruses themselves could be targeted by the host PTGS machinery. (Baulcombe, 1996)
Since then extensive work has been performed in every possible gene regulatory pathway in all the established models, resulting in very important findings. These results have established RNAi as a powerful tool in biological sciences that have implications in different frontiers of science - chromatin remodeling, genomic imprinting, X-inactivation, transposon repression, plant anti-viral mechanisms, stem cell differentiation, and in technology - disease diagnosis and prognosis, siRNA therapeutics, global gene expression study tool. (Cohen et al, 2002, Cavalli et al, 2002)
Our lab members have been pioneers in this area of research, contributing several milestones in unraveling the nuances of RNAi.  As early as 1997, when there was no speculation of co-suppression in animals, Pal-Bhadra et al published the initial reports of co-suppression in Drosophila. When two to six copies of a white promoter-Alcohol dehydrogenase (Adh) reporter fusion gene were introduced into the genome, the expression of Adh was reduced, proportionate to the copy number increase of w-Adh, both in larvae and adults, rather than the expected gene dosage effect. This result showed a strong analogy to ‘‘co-suppression’’ phenomena described in many plant species. Silencing of the Adh gene was strongly affected by the Polycomb and Polycomb like mutations. Polycomb and Polyhomeotic proteins were found to be bound to the chromatin at repressed w-Adh transgene insertion sites.
In 2002, two types of silencing were found to be interconnected using Alcohol dehydrogenase (Adh) transcription unit as a marker. Though multiple copies of w-Adh hybrid gene underwent Polycomb dependent transcriptional gene silencing (TGS), full-length Adh transgenes have shown post-transcriptional silencing (PTGS). The post-transcriptional gene silencing (PTGS) exhibited molecular hallmarks typical of RNA interference (RNAi) such as production of 21–25 bp length sense and antisense RNAs homologous to the silenced Adh mRNA. Early genetic screens identified P-element induced wimpy testis as one of the resultant phenotypes of mutations in RNAi based gene silencing pathways. Mutations in piwi, a core member required for RNAi, block PTGS and one aspect of TGS, indicating a connection between the two types of silencing.
In 2004, using tandem mini-white arrays and white transgenes that form heterochromatin like structure, it was shown that position effect variegation (PEV) was dependent on RNAi machinery. By this period the Argonaute family proteins gained importance as having major roles in RNAi. Loss of silencing as seen in PEV was associated with the loss of Argonaute family proteins like Piwi and Aubergine. A considerable reduction of H3Lys9 methylation and simultaneous delocalization of HP1 and HP2 was contributed by these mutations.
The main objectives of this work were a sequel to the initial findings of the lab. In continuation with the investigations ongoing in the lab the objective was to dissect the proteins involved in the formation of a silencing complex at the transcriptional level. In fission yeast the role of RNAi in Transcriptional Gene Silencing was studied extensively and the presence of the RITS (RNA induced Transcriptional Silencing complex) was found, though concrete evidence for a similar complex, in Drosophila was lacking. Since the earlier work, confirmed the interconnecting role of PIWI in TGS and PTGS, this protein was used as an anchor to investigate the interacting proteins in Drosophila. 
Piwi is expressed in the germline and in early embryos. It plays a role in transposon silencing in the germplasm with the association of a species of small regulatory RNA (Saito et al, 2006) but little is known about its role in the early embryos. Since PIWI poses an interconnecting link between TGS and PTGS we hypothesized that it may have multiple roles in nucleus and cytoplasm. Our main objective was to explore whether nuclear PIWI plays a role in TGS pathway by interacting with other critical heterochromatic proteins and to investigate other possible roles of cytoplasmic PIWI in early embryogenesis. 
On extensive chromatographic purification followed by mass spectrometric identification, we got a number of heterochromatic, chromatin bound and dosage compensation related proteins indicating a major role of nuclear PIWI in chromatin regulation. Apart from these results we observed PIWI interaction with distinct families of proteins sharing common domains, like RNA binding domains indicating the intimate association of RNA. Cytoplasmic PIWI interacted with a number of ribosomal proteins, both small and large subunits, translational machinery proteins and nuclear trafficking proteins indicating cellular dynamics. Since our work has indicated distinct groups of interactions in the two cellular compartments, PIWI in early embryos could be implicated in chromatin division encompassing all the cellular compartments.  
As small RNA pathways have a central role in these activities, we characterized the RNA associated with both nuclear and cytoplasmic PIWI. Since RNA plays an important role in the function of these protein complexes the extent of RNA dependence was also evaluated. Nuclear PIWI protein interactions were largely stable even without the presence of any RNA, although there was a reduction in molecular mass and split in the groups of interactions. Whereas PIWI in the cytoplasm associated with high molecular weight RNA and ribosomal proteins indicating its intricate association with polysomes apart from its individual interactions. Our findings put together with the existing reports point to many distinct groups of protein RNA interactions of Piwi in the proximity of the chromatin rather than a single stable complex in the nucleus. Moreover the simultaneous interactions of Piwi with polysomes could indicate a cycle of functional trafficking between the nucleus and cytoplasm in early embryogenesis.
Small RNA pathways are vital mechanisms for genome regulation at the epigenetic level. Per se epigenetic regulation is a phenomenon that is responsible for generating and maintaining diversity of cell types during development and stability of the genome. Epigenetics basically involves modifications at the DNA and Histone level. Changes in packaging of genomic DNA along with histone proteins leads to the remodeling of chromatin structure (Van Holde K 1998). The majority of nucleosomes in the cell are composed of the same four types of core histones, but tremendous diversity in the histone/nucleosome structures is generated by a variety of post-translational modifications, such as acetylation, phosphorylation, methylation, and ubiquitination (Iizuka M and Smith MM 2003) Modifications of the core histones H2A, H2B, H3, H4 and histone variants such as H2A.Z and H3.3, are implicated in gene regulation. These modifications are collectively referred to as the histone code (Jenuwein et al 2001). Histone methylation and histone variants have a major role in heterochromatin assembly and the maintenance of the boundaries between heterochromatin and euchromatin. Many of these modifications are specific for heterochromatin such as methylation of histone H3 lysine 9 and histone H3 lysine 27 (Silva et al 2003) and for euchromatin, it is histone H3 lysine 4. (Lachner et al, 2002) Chromatin associated proteins such as HP1, Pc, Swi6 identify these specific histone tail modifications and initiate the formation and maintenance of heterochromatin. 
RNAi based small RNA pathways control chromatin modifications endogenously. But epigenetic modifications can also be caused during therapeutic conditions or cellular stress by other exogenous factors like ionizing radiations or small molecules. Small molecule inhibitors of protein kinases and phosphoproteins, key players of cellular activity, are known for many years. Recently, small molecule miR-21 inhibitors have been developed using luciferase reporter assays in mammalian cells which are undergoing trials for treatment of cancer and heart failure. (Gumireddy K et al, 2008) Inducible reverse two-hybrid assay in yeast have revealed small molecule inhibitors of protein–protein interactions which have a key role in most biological processes, and offer attractive opportunities for therapeutic intervention (Arkin MR and Well JA, 2004) Discovery of newer therapeutic molecules and their bioevaluation is a major task that complements discoveries in basic research. Our second objective was to screen a small molecule natural product library extracted in-house, for possible histone code modifications which lead to chromatin remodeling and a phenotype that is beneficial.
Natural flavonoids, predominantly found in edible fruits and vegetables, exhibit many biological activities. Plant flavonoids extracted, purified and characterized from a medicinal plant Oroxylum indicum were evaluated for their anti-cancer properties and correlating histone modifications caused at the global level. DNA analysis of drug exposed cancer cells, establish cell cycle arrest at the G1 phase on a synchronized population. On dissecting the G1 phase checkpoints we found p21 over-expression as compared to the controls. To estimate the levels of histone code changes associated with the flavonoid induced growth arrest, we analysed the levels of methylation in H3K9 and acetylation in H3K12 and H4K16. Global histone code modifications associated with the growth arrest could indicate their role in gene specific changes. 
Genomic instability caused by way of ionizing radiations, have been investigated extensively. DNA double strand breaks and the resulting induction of ATM is a known fact when cells are exposed to stressful conditions like gamma radiations. MOF (males absent on the first) is a member of the MYST family of histone acetyltransferases and was originally discovered as an essential component of the dosage compensation system in Drosophila, enhancing the level of transcription of the single X in males relative to the double X chromosome in females. Binding of the dosage compensation complex, involving MSL1, MSL2, MSL3, MLE and MOF to the X chromosome in somatic cells of males but not of females is correlated with a significant increase in histone 4 acetylated at lysine 16, on this chromosome. (Gu W et al, 1998) 
hMOF, the human ortholog of the Drosophila MOF gene (males absent on the first), encoding a protein with histone acetyltransferase activity, interacts with the ATM (ataxia-telangiectasia-mutated) protein. (Gupta A et al, 2005) Although the molecular function of MOF is conserved, it performs a different role in mammals and in flies at the organism level. Therefore we wanted to study the effects of ionizing radiation on the Drosophila system, with respect to MOF and its substrate H4K16. We found the levels of acetylation in H4K16 significantly higher after exposure to gamma radiation. We also studied the localisation pattern of MOF and H4K16 on somatic cell chromosomes upon gamma irradiation.
If drug invention/discovery is one major hurdle, equally intimidating is the delivery of these drugs with a significant therapeutic index. The last objective was to develop a novel delivery vehicle for small regulatory RNA in vivo. Although, introduction of dsRNA appears to be a powerful therapeutic method in human disease, its commercialization has suffered mainly due to the hurdles of efficient delivery of siRNA or dsRNA and its biocompatibility and stability in tissues. Novartis, Alnylam and other leading pharmaceuticals have started employing different drug delivery vehicles for therapeutic siRNA delivery. However complete success in these ventures was hard to achieve due to practical constraints. We have evaluated a novel delivery device for effective dsRNA or siRNA delivery, namely PABA nanotubes. Materials that are more natural to the human body, if compatible for self assembly into nano level structures, would be most ideal for biomedical and biosensor applications. On these lines para amino benzoic acid which is a structural moiety of Folic acid (Vitamin B family) was employed for self assembly into nanotubes. These nano level structures were conjugated with either green or red fluorescence to enable in vivo tracking. As an ancillary objective, we wanted to estimate the efficiency of in-vivo and in vitro delivery of PABA nanotubes by fluorescence tracking. We found these PABA nanotubes posed excellent biocompatibility when evaluated in Drosophila and human cell lines. Their internalization was studied with advanced microscopic and flow cytometric techniques.


